Skip to main content
ATRA logo
ATRA
(NASDAQ)
Atara Biotherapeutics, Inc.
$9.45-- (--)
Loading... - Market loading

Atara Biotherapeutics (ATRA) Stock Price & Financial Analysis

Atara Biotherapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$9.00 - $9.63
52-Week High$19.15
52-Week Low$3.92
Open$9.61
Volume80.24K
Average Volume (3M)2.85M
Market Cap134.72M
Shares Outstanding14.32M
P/E Ratio (TTM)4.12
Price to Sales (P/S)1.12
Price to Book (P/B)-3.50
EV/EBITDA3.82
Revenue (TTM)120.77M
Net Income (TTM)32.69M
Free Cash Flow (TTM)-50.94M
EPS (TTM)$2.56
Profit Margin27.07%
Operating Margin30.20%
50-Day MA$5.47
200-Day MA$10.23
52-Week Change35.70%
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%

Frequently Asked Questions About Atara Biotherapeutics

What is the current stock price for ATRA?

As of the latest trading session, ATRA stock trades at $9.45. The 52-week range is $3.92–$19.15, with a day range of $9.00–$9.63.

What is the P/E ratio for ATRA?

Atara Biotherapeutics's trailing P/E ratio is 4.1, meaning investors pay $4.1 for every $1 of annual earnings. Atara Biotherapeutics operates in the Healthcare sector.

Does ATRA pay dividends?

Atara Biotherapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for ATRA?

Analyst ratings and recommendations for ATRA are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.

What is the market cap of ATRA?

Atara Biotherapeutics's market capitalization is $135.3M, classifying it as a micro-cap company. Atara Biotherapeutics operates in the Healthcare sector within the Biotechnology industry.